Emma Björk

Emma Björk

Auto-generated profile, based on publicly available information

Emma Björk

Division of Obstetrics and Gynecology/Örnsköldsvik Hospital Örnsköldsvik Sweden

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 July 2024 in The Journal of Immunology
Verified
Journal Article
Closed access
EBEmma Björk
Emma Björk
PIPernilla Israelsson
Pernilla Israelsson
INIvan Nagaev
Ivan Nagaev
ONOlga Nagaeva
Olga Nagaeva
ELEva Lundin
Eva Lundin
LMLucia Mincheva-Nilsson
Lucia Mincheva-Nilsson
Endometriosis, affecting 10% of women, is defined as implantation, survival, and growth of endometrium-like/endometriotic tissue outside the uterine cavity, causing inflammation, infertility, pain, and susceptibility to ovarian cancer. Despite extensive studies, its etiology and pathogenesis are poorly understood and largely unknown. The prevailing view is that the immune system of endometriosis patients fails to clear ectopically disseminated endometrium from retrograde menstruation. Exosomes are small extracellular vesicles that exhibit immunomodulatory properties. We studied the role of endometriotic tissue–secreted exosomes in the pathophysiology of endometriosis. Two exosome-mediated mechanisms known to impair the immune response were investigated: 1) downregulation of NKG2D-mediated cytotoxicity and 2) FasL- and TRAIL-induced apoptosis of activated immune cells. We showed that secreted endometriotic exosomes isolated from supernatants of short-term explant cultures carry the NKG2D ligands MICA/B and ULBP1-3 and the proapoptotic molecules FasL and TRAIL on their surface, i.e., signature molecules of exosome-mediated immune suppression. Acting as decoys, these exosomes downregulate the NKG2D receptor, impair NKG2D-mediated cytotoxicity, and induce apoptosis of activated PBMCs and Jurkat cells through the FasL- and TRAIL pathway. The secreted endometriotic exosomes create an immunosuppressive gradient at the ectopic site, forming a “protective shield” around the endometriotic lesions. This gradient guards the endometriotic lesions against clearance by a cytotoxic attack and creates immunologic privilege by induction of apoptosis in activated immune cells. Taken together, our results provide a plausible, exosome-based mechanistic explanation for the immune dysfunction and the compromised immune surveillance in endometriosis and contribute novel insights into the pathogenesis of this enigmatic disease.

4 February 2026 in American Journal of Reproductive Immunology
Verified
Journal Article
Open access
EBEmma Björk
Emma Björk
PIPernilla Israelsson
Pernilla Israelsson
ONOlga Nagaeva
Olga Nagaeva
LMLucia Mincheva-Nilsson
Lucia Mincheva-Nilsson
UOUlrika Ottander
Ulrika Ottander
Problem: NK‐cell dysfunction in endometriosis is suggested to contribute to the survival of ectopic endometrial tissue. However, the underlying causes of this impairment remain unclear. NK cells are divided into: CD56 +bright , which produce high amounts of cytokines but have low or no cytotoxic ability, and CD56 +dim , which are mainly cytotoxic. CD56 +bright NK cells, constitutively present in human endometrium (eNK cells), represent only 0–2% of NK cells in PBMC, where CD56 +dim cells dominate. Method of Study: NK‐cell subpopulations and NKG2D receptor expression in PBMC were analyzed by flow cytometry in two cohorts of untreated and treated endometriosis patients and healthy age‐matched controls. Results: Elevated numbers of CD56 +bright cells were observed in 8 of 21 untreated endometriosis patients compared to controls. These numbers were normalized following surgery and hormonal treatment. The NKG2D receptor expression was reduced in untreated patients compared to controls and treated patients. Conclusions: The significantly increased proportion of peripheral CD56 +bright  NK/eNK cells may result from migration of these cells from ectopic endometrial tissue. The downregulation of NKG2D receptor expression in PBMCs may be mediated by immunosuppressive endometriotic exosomes, as previously reported by us. Taken together, our results suggest that: (1) the impaired NK cell cytotoxicity in untreated endometriosis patients may be due both to an influx of CD56 +bright /eNK cells and exosome‐induced NKG2D receptor downregulation; and (2) elevated numbers of peripheral CD56 +bright NK cells could be considered as a potential diagnostic marker for endometriosis.